Healthcare giant Johnson & Johnson (NYSE:JNJ) may have found a buyer for its Cordis business, according to Bloomberg News.
Varicose vein treatment: VenaSeal wins FDA approval
Covidien‘s VenaSeal closure system to treat varicose veins has been approved by the U.S. Food and Drug Administration, according to an agency press release.
Report: Infraredx delays $56M IPO
C.R. Bard scores reimbursement win for Lutonix
Report: Lumenis in talks to be acquired by Fosun for $480M
Lumenis Ltd., which raised nearly $100 million through an initial public offering on NASDAQ last year, is in talks to be acquired by Chinese conglomerate Fosun for nearly $500 million, according to the Israeli financial newspaper Calcalist.
Layoffs: Integra Lifesciences cuts nearly 50 jobs from Massachusetts facilities
Integra LifeSciences (NSDQ:IART) cut 49 jobs from its Massachusetts facilities late last year, according to a WARN notice filed with the Commonwealth.
Allergan name to live on post Actavis merger
SEMDA taps AdvaMed’s Jason Rupp for executive director role |Personnel Moves
Pelvic Mesh lawsuits: J&J drops claim that women were asked to lie for payouts
Johnson & Johnson (NYSE:JNJ) has withdrawn its motion to have a federal judge overseeing thousands of pelvic mesh lawsuits to force the plaintiffs to prove they have a valid claim.
Weight loss: ReShape Medical closes $6.75M funding round
ReShape Medical, the medical device maker developing a balloon system to combat obesity has raised nearly $7 million through a debt financing round, according to regulatory filings.